Introduction: Evidence suggests that toxic iron is involved in haemophilic joint destruction.
| INTRODUC TI ON
Arthropathy caused by frequent spontaneous joint bleeding is a progressive and debilitating co-morbidity in haemophilia. 1 The most salient features of haemophilic arthropathy are intra-and periarticular soft tissue inflammation with hypertrophy and osteochondral destruction. [2] [3] [4] [5] In addition to insufficient plasma clotting factor activity levels, vascular instability caused by neovascularization, vessel remodelling and abnormal vessel leakiness may fuel a vicious cycle of re-bleeding, thereby promoting arthropathic progression. 3, [6] [7] [8] Supported by observations from explanted cartilage and haemophilia mouse and dog models, the concept has emerged that iron released from red cells and subsequently stored as hemosiderin in articular soft tissues creates a 'toxic' environment. 9 As a consequence, dysregulation of joint tissue metabolism, synovial inflammation and hypertrophy occur, ultimately resulting in cartilage destruction. 5 However, a more exact understanding of the influence of joint iron deposition on clinical outcomes and the progression of arthropathy in relation to imaging findings in patients with haemophilia (PWH) is lacking.
The purpose of this study was to evaluate joints of adult PWH using conventional and quantitative ultrashort time-to-echo (UTE) magnetic resonance imaging (MRI) sequences to delineate imaging pathology according to IPSG recommendations, 10 which also assess hemosiderin content semi-quantitatively, and to determine whether findings correlate with Hemophilia Joint Health Scores (HJHSs) and pain. Ultimately, we felt that such knowledge would improve our clinical understanding of haemophilic arthropathy and help to optimize the use of clinical and radiological assessments for therapeutic management.
| MATERIAL S AND ME THODS

| Patient population and data extracted
Adult patients with haemophilia A or haemophilia B of all severities (denoted as severe, moderate or mild depending on intrinsic factor FVIII or IX plasma activity of <1%, 1%-5% or ≥5%, respectively), age 21 years and older (n = 23), and seen consecutively during routine clinic visits over a 4-month period, underwent MRI examination of one painful or uncomfortable joint. At inclusion, Hemophilia Joint Health Scores (version 2.1) of the affected joints 11 (HJHS, 0 best, 20 worst) were determined for the affected joint by a licensed physical therapist with >5 years of general practice experience and approximately 2 years of experience with haemophilia patients. The physical therapist was trained in the HJHS acquisition according to instructions and guidance provided by online training and video modules developed by the International Prophylaxis Study Group (http://www.ipsg.ca/publi catio n/hemop hilia-joint-health-score-instr uctio nal-video-and-manual). Pain was self-assessed by visual analogue scale (VAS; 0 no pain; 10 worst pain). In terms of patient demographics, only age, type and severity of haemophilia were extracted from the electronic medical record.
The study protocol, data acquisition and patient confidentiality safeguards were approved by the Human Research Protection Program (HRPP) at the University of California San Diego (UCSD), and patients provided written informed consent. matrix, 14-cm field of view, time ~6 minutes). 12 Intravenous contrast was administered for select cases when clinically indicated.
| MR imaging
| Image interpretation and data analysis
The International Prophylaxis Study Group (IPSG) MRI score 10 was applied by a fellowship-trained, musculoskeletal radiologist with 6 years of experience and a fourth-year radiology resident. Both were blinded to each other's scores as well as clinical scores. The soft tissue domain, composed of effusion/hemarthrosis, synovial hypertrophy and hemosiderin, has a maximum score of 9. The osteochondral domain, composed of surface erosions, subchondral cysts and cartilage degradation, has a maximum score of 8. The IPSG MRI score has a maximum combined score of 17. The presence and extent of hemosiderin deposition were determined by evaluating the multi-echo UTE sequence, with special consideration to avoid misinterpreting as hemosiderin chemical shift artefacts of the second kind for voxels containing both fat and water on out-of-phase TEs. 13 Using the sagittal multi-echo UTE images, a slice extending through the centre of each articulation was selected, and regions of interest (ROIs) were carefully placed on the midportion of the patellar and talar cartilage (weight-bearing articulations) on the selected slice. Most elbows exhibited severe osteochondral wear with little or no cartilage left for quantitative MRI analysis and therefore were excluded from further analyses. ROIs were selected to minimize volume averaging artefacts. T2* values were calculated using a Levenberg-Marquardt fitting algorithm developed in-house in MATLAB (The Mathworks Inc).
| Human joint tissue and histology
The harvesting of human tissues at the time of total knee replacement surgery was approved by the UCSD HRPP. To assess cartilage changes and iron deposition by histopathology, bone pieces containing articular cartilage were sawed into approximately 2 × 1 cm pieces and fixed in formalin for >1 week. Pieces were rinsed and demineralized by daily changes of 10% formic acid in the presence of 0.2% potassium ferrocyanide to achieve en bloc Perls' reaction before loss of ferric ions in the acid demineralization solution. Decalcification included 5 days of formic acid, followed by 5 days of saline rinsing. Pieces of decalcified Perls'-reacted tissue were cryoprotected in 30% sucrose and cryosectioned at 8 μm before counterstaining with haematoxylin or periodic acid-Schiff stain. To limit staining to only light red nuclei with haematoxylin, modified Harris haematoxylin (SH30, Fisher Scientific) was mixed 1:2 with 0.5% aqueous acetic acid and applied for only 1 minute before differentiation in 70% ethanol with 1% HCl.
| Statistical analysis
Descriptive statistics were used to describe the patient cohort.
Correlations between cartilage (T2*) MRI findings with pain, HJHS and MRI IPSG score were achieved by Spearman rank test. The consistency between the two radiologists was evaluated with the intraclass correlation coefficient. 13 
| RE SULTS
| Patient and joint characteristics
The cohort characteristics are summarized in Table 1 
| Relationships between IPSG MRI scores, pain and HJHS
There were no significant correlations between VAS pain scores and HJHSs with the MRI IPSG scores, either total or divided into soft tissue or osteochondral sub-scores. Charting of data correlations revealed that advanced MRI findings, represented as total IPSG score, or subdivided into the osteochondral and soft tissue domains, could be present at low HJHSs already, or even at a HJHS of zero.
However, most abnormal MRI scores appeared above a HJHS of 3 ( Figure 1 ). 
| Quantification of iron in cartilage by MRI T2* relaxation and the relation to HJHS
| Histological analysis of explanted cartilage for iron loading
To prove iron accumulation in cartilage as suggested by MRI, we examined cartilage explants, harvested subsequently (within 2 years) from two of the patients undergoing total knee replacement surgery.
The corresponding T2* relaxation times in the patellae were 4. 
| D ISCUSS I ON AND CON CLUS I ON
Quantitative MRI has been widely implemented for non-invasive evaluation of hyaline articular cartilage. 14 Several studies have shown that chondral T2 and T2* relaxation times are sensitive to water content, collagen content and collagen fibril orientation. [15] [16] [17] Classically, elevated T2 values in cartilage have been considered to represent irreversible damage to the extracellular matrix. 18 Most recently, investigators have demonstrated that T2*, as measured by a multi-echo UTE technique similar to that used in this study, was significantly elevated in cartilage of injured knees compared with uninjured controls. 19, 20 Based on these results from studies in nonhaemophilic populations with injury or osteoarthritis, we expected to find a positive correlation between increasing T2* relaxation times and worsening joint status. However, we found a strong negative correlation between joint status determined by HJHS and MRI IPSG scores with relaxation times. This seemingly contradictory and surprising result may be explained by our histology results showing iron accumulation in the cartilage, which would decrease T2*. 21 The strong negative correlation suggests that the T2* shortening is a result of severe chondral iron deposition dominating the effects. 
(C) (D)
Iron deposition in chondrocytes of deteriorating cartilage in humans was described decades ago in several case series of patients with hemochromatosis. [22] [23] [24] However, not all studies analysing arthritic joints of patients with hemochromatosis have identified iron in cartilage while synovial iron was readily detectable. 23, 25, 26 It has been suggested that the paucity of observations of iron in cartilage may be due to the lack of sensitivity of osteochondral iron to usual iron stains (such as Prussian blue/Perls' stain) in histological examinations, since iron particles are small (0.25-0.5 μ) and may be beyond microscopic resolution, or to the loss of iron due to acidic fixation and decalcification techniques of joint tissue. 22 This has been elucidated by Ghadially et al 22 where iron detection with light microscopy after Prussian Blue/Perls' staining was compared to electron probe X-ray analysis of articular cartilage of rabbits after induced chronic hemarthrosis. In keeping with this observation, abundant synovial hemosiderin has been reported in haemophilic joints, whereas cartilage iron deposition has only been described in one case by light microscopy. 27, 28 To our knowledge, there is only one additional case report, describing iron accumulation in cartilage in association with chronic hemarthrosis, but without an evident cause such as haemophilia. 29 Taken together, it appears that iron can accumulate in cartilage with or without hemarthrosis, but little to nothing is known about the mechanistic and molecular processes of cartilage iron loading, or its clinical consequences.
In hemochromatosis, it has been proposed that iron might contribute to the degeneration of cartilage, but a direct relationship between joint iron accumulation and degree of arthritis has not been established. 28, 30, 31 To date, there is no knowledge about the extent of iron accumulation in cartilage of haemophilic joints in relation to joint status, function or dynamics of joint deterioration.
Somewhat surprisingly, observations from this study demonstrated that there was no correlation between clinical (HJHS) and imaging (MRI) scores, with highly abnormal imaging findings present over a wide spectrum of clinical scores. Similarly, widely divergent and mostly poor correlations between MRI IPSG scores and HJHS were reported previously, [32] [33] [34] especially in relation to the soft tissue compartments, 32 possibly dependent on joint type and articulations involved. 34 These findings suggest that, while depicting joint deterioration, imaging abnormalities may have limited bearing on clinical joint status, which may be driven at least in part by individual pain perception and functional mobility. In aggregate, these observations corroborate that the severity of imaging findings can be dissociated from clinical/functional joint status as has been observed in other arthritic conditions. 35 However, when imaging was focused on chemical iron quantification using T2* relaxation, significant correlations between iron content and clinical scores as well as imaging scores became evident. Reasons are unclear, but also indicate that both are affected proportionally by cartilage iron loading. These findings suggest that (a) iron accumulation in association with joint bleeding occurs in cartilage and not solely in synovial tissue as previously believed and (b) that iron, once deposited in cartilage, may play an important role for direct and continued cartilage toxicity, destruction and the progression of haemophilic arthropathy. This is of importance since osteochondral changes in haemophilia are believed to be mediated more indirectly by the pro-inflammatory milieu created by iron in synovial fluid and the synovium 5,36 rather than by direct deposition of iron in cartilage. In that sense, the pathways of iron uptake into cartilage and iron retention, potentially causing damage from 'inside-out' rather than from 'outside-in', as well as the potential for reversibility of cartilage iron loading are unknown.
These findings suggest a need not only to study molecular path- Traditionally, the reduction of symptomatic joint bleeding, often expressed as annual bleeding rate (ABR), has been the most important outcome parameter for clotting factor therapies. However, ABR may be insufficient to guide management decisions for (a) emerging nonfactor therapies, such as the recently FDA-approved FVIII-mimetic emicizumab (Hemlibra ® , Genentech) improving coagulation profiles and (b) gene therapies on the horizon with anticipated constant elevation of plasma factor activity levels. 41 Since these new therapies mitigate or abrogate the fluctuations between plasma peak and trough clotting factor activity levels, correction of subclinical bleeding (rather than overt clinical bleeding) and appropriate iron clearance from the joint is important. It is in this arena that hemosiderin quantitation in joints could become a valuable assessment tool to measure treatment success. In that sense, interval detection of accumulation of hemosiderin during long-term treatment plans, employing non-factor or clotting factor strategies, would indicate that the prescribed therapy may not be adequate. Optimization of therapy may be achieved by discussing improved compliance, switching strategies, and/or adjustments with respect to dosing and/or frequency of drug administration.
In summary, it appears important to recognize that hemosiderin accumulation occurs not only in synovium, but also in cartilage, a fact that may be generally underappreciated in haemophilia care due to difficult histological detection by conventional iron staining methods. Since findings from our study revealed that the amount of cartilage iron is associated with deteriorating clinical and imaging joint status, we hypothesize that cartilage iron plays a significant role in the progression of haemophilic arthropathy. Therefore, cartilage iron could be considered a biomarker of joint health that may become directly quantifiable with innovative joint-specific MRI T2* sequences, thus guiding the adjustment of therapeutic strategies to optimize joint health in patients with haemophilia.
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